About
Tony Ho previously served as Executive Vice President and Head of Research and Development at CRISPR Therapeutics, where he built an R&D pipeline that advanced multiple candidates into the clinic, including CTX001 and several allogeneic CAR-T programs. Before that, he held senior roles at AstraZeneca overseeing oncology programs such as Lynparza and Imfinzi, led Neurology and Ophthalmology at Merck, and co-founded Neuronyx as its CSO. He holds a B.S. in Electrical Engineering from UCLA and an M.D. from Johns Hopkins, and holds academic appointments in neurology at the University of Pennsylvania and Johns Hopkins.
Invests in
BiotechHealthtechMedical Devices
Experience
- Pivotal LifesciencesChief Scientific Officer & Senior Science Partnercurrent2022 β presentBoston, Massachusetts, United States
- Self-employedBiotech Entrepreneurcurrent2022 β presentBoston, Massachusetts, United States
- CRISPR TherapeuticsExecutive Vice President and Head of Research and Development2017 β 2021Greater Boston Area
- AstraZenecaHead of Oncology Innovation and Integration, Senior Vice President2012 β 2017Washington D.C. Metro Area
- AstraZenecaGlobal Medicine Leader Imfinzi (Durvalumab/MEDI4736), Vice President Immuno-Oncology2012 β 2017
- AstraZenecaGlobal Product Vice President, Olaparib, Oncology GMED2012 β 2015United States
- AstraZenecaVice President, Clinical Innovative Medicine- New Opportunities2012 β 2013
- Merck & Co., Inc.Neurology & Ophthalmology Section Head/ Executive Director2003 β 2011
- Merck & Co., Inc.Senior Director Clinical Neuroscience and Ophthalmology2007 β 2010
- NeuronyxCo-founder, Chief Scientific Officer, Senior Vice President of R & D2000 β 2003
- Johns Hopkins UniversityAssistant Professor of Neurology1997 β 2000
- Johns Hopkins HospitalNeurology Residency & Fellowship1992 β 1997
- Massachusetts General HospitalInternship1991 β 1992
Education
- The Johns Hopkins University School of MedicineM.D., Medicine1987 β 1991
- UCLAB. S., Electrical Engineering1985 β 1987
- Katella High School1980 β 1984
Skills & more
CTMS14Neuroscience99Medicine23Clinical Development99Clinical Research66Clinical Trials31Drug Development99Neurology56Innovation5Parkinson's5Ophthalmology7Migraine4
+12 more
BiotechnologyPharmaceutical IndustryDrug DiscoveryGCPNeuropathic PainStrokeAlzheimer's diseaseGlaucomaDry EyeBusiness DevelopmentOsteoporosisNeurodegenerative DiseaseFrom Tony's professional profile.
Same school
Also attended The Johns Hopkins University School of Medicine25
Hal PazInvestor at Khosla VenturesBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesSamantha GuinnAnalyst at Novartis Venture FundGreg HornerInvestor at Sand Hill Angels
+ 19 more
Also attended UCLA374
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzRon ConwayFounder of SV AngelKirsten GreenFounder and Managing Partner at Forerunner VenturesPaul FieldingFinance & Operations at General CatalystMelody MaExecutive Assistant and Lead Receptionist at Trinity VenturesGizem CakilInvestor at OpenView Venture Partners
+ 368 more
Shared employers
Also worked at CRISPR Therapeutics5
Also worked at AstraZeneca52
Jung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyAnnie VemuSenior Associate at Longwood FundIliam BarkinoInvestor at IndustrifondenSara JawadInvestor at IndustrifondenDamian Crowtherex-AstraZeneca at PICUS CAPITAL
+ 46 more
Also worked at Merck & Co., Inc.90
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock VenturesDavid KaufmanInvestor at Third Rock Ventures
+ 84 more
Also worked at Johns Hopkins University43
Demi ObayomiPrincipal at Sapphire VenturesCaitlinChief of Staff at Hummingbird VenturesJun JeonInvestor at Khosla VenturesLinda CuretonBoard Member at Maryland TEDCOCharlie BuffaVice President, Sales at Mainsail PartnersOluwakayode (Kay) JasanyaInvestor at SUPPLY CHANGE CAPITAL
+ 37 more
Colleagues at Pivotal Life Sciences
AJ Velasquez-Mao
Investor at Pivotal Life Sciences
Benjamin Li
Vice President at Pivotal Life Sciences
Brian Mills
Vice President at Pivotal Life Sciences
David Malek
Venture Partner at Pivotal Life Sciences
Glenn Batchelder
Venture Partner at Pivotal Life Sciences
Jeni Lee
Partner at Pivotal Life Sciences
Joseph Charalel
Vice President at Pivotal Life Sciences
Kayla Han
Investment Associate at Pivotal Life Sciences



.png)































